Bioengineering Imaging Group
The Bioengineering Imaging Group is a world-leader in the development of the imaging needle technology for clinical use.
Our team design and build highly miniaturised imaging probes to help diagnose disease and enable safer surgery. Our imaging needles consist of a tiny fibre-optic probe encased in a hypodermic needle. These devices are able to provide guidance deep within the body with fluorescence imaging and optical coherence tomography.
Based in the ARC Centre of Excellence for Nanoscale Biophotonics (CNBP), which is part of the Institute for Photonics and Advanced Sensing (IPAS), the Bioengineering Imaging Group has strong research programs in the development of new optical imaging technologies and clinical translation.
Our research team is a multi-disciplinary group of engineers, physicists and computer scientists who work together with clinicians. Our skills complement the expertise already within the CNBP. Together, we are exploring novel applications and deployment of optical fibre sensing and imaging across medicine and physiology.
Professor Robert McLaughlin
Professor Robert McLaughlin is Head of the Bioengineering Imaging Group, Chair of Biophotonics at the University Adelaide and Managing Director of the imaging company, Miniprobes. He has a PhD in Electronic Engineering and was a post-doctoral researcher at The University of Oxford. He worked for several years in the medical device industry where he was responsible for the development and commercial release of three medical devices.
Related areas of research
We offer exciting opportunities for researchers at the honours, masters and PhD levels. Our research degrees are open to students from a broad range of backgrounds, and range from basic sciences to clinical research. If you are interested in human health, consider furthering your research career with us.